SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	$ (192)	$ (17)	$ (5)	$ 112
Intangible asset amortization expense	167	157	333	319
Operating income (loss)	(192)	(17)	(5)	112
Interest expense, net	85	124	163	241
Other (income) expense, net	(20)	42	(27)	40
Loss from continuing operations before income taxes	(257)	(183)	(141)	(169)
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	525	514	1,060	974
Operating income (loss)	525	514	1,060	974
Operating Segments | Medical Products and Therapies
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	238	264	465	461
Operating income (loss)	238	264	465	461
Operating Segments | Healthcare Systems and Technologies
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	120	100	187	212
Operating income (loss)	120	100	187	212
Operating Segments | Pharmaceuticals
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	75	89	153	176
Operating income (loss)	75	89	153	176
Operating Segments | Kidney Care
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	83	55	242	112
Operating income (loss)	83	55	242	112
Operating Segments | Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	9	6	13	13
Operating income (loss)	9	6	13	13
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Unallocated corporate costs	(3)	(25)	(23)	(46)
Intangible asset amortization expense	(167)	(157)	(333)	(319)
Goodwill impairment	(430)	0	(430)	0
Business optimization items	(20)	(293)	(77)	(427)
Acquisition and integration items	(6)	(7)	(11)	0
Separation-related costs	(81)	(37)	(173)	(46)
European Medical Devices Regulation	$ (10)	$ (12)	$ (18)	$ (24)